AUTOLOGOUS ADIPOSE DERIVED STROMAL VASCULAR FRACTION FOR THE TREATMENT OF INTERSTITIAL CYSTITIS-A PILOT STUDY

AUTOLOGOUS ADIPOSE DERIVED STROMAL VASCULAR FRACTION FOR THE TREATMENT OF INTERSTITIAL CYSTITIS-A PILOT STUDY Elliot B. Lander MD, Mark H. Berman MD, Jackie R. See MD California Stem Cell Treatment Center and Cell Surgical Network INTRODUCTION: We evaluated the safety and efficacy of deployment of SVF Stromal Vascular Fraction (rich in adult mesenchymal stem cells…

Details

Cell Surgical Network Study for Stromal Vascular Fraction Registered by ClinicalTrials.gov

Rancho Mirage, CA (PRWEB) October 14, 2013 Clinicaltrials.gov, a service of the U.S. National Institutes of Health has registered on their public site an IRB approved safety study from the Cell Surgical Network, Inc.. This study is available for patients with various degenerative and inflammatory conditions to undergo Stromal Vascular Fraction deployment for the evaluation and for the…

Details

Dr. Berman’s 2013 Speaking Engagements

Mark Berman, MD, FACS wants you to come see him speak at healthcare conferences around the world.  This year, he is discussing cosmetic procedures and stromal vascular fraction (SVF) at the following seminars: American Academy of Cosmetic Surgery (AACS) Invited Guest Speaker Breast and Body Contouring Course St. Louis, MO April 18-20, 2013 http://www.cosmeticsurgery.org/ Clinical…

Details

Dr. Elliot Lander is presenting 2 abstracts at the American Urologic Association November 2013 meeting about SVF and complex urologic diseases.

News Flash: Dr. Elliot Lander, co-medical director of the Cell Surgical Network, will present 2 research abstracts at the American Urologic Association Western Section Annual Meeting in Monterey California Nov 2013. These abstracts will highlight some of our ongoing studies for the use of SVF (rich in mesenchymal stem cells and growth factors) to treat…

Details